Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF12A
NM
Basal B
ICRF-193
TOP2
TOP
10817.151
uM
0.37684
0.14924
0.3567 0.3698 1.4529 0.2738
0.9944
1.4848
MCF12A
NM
Basal B
IKK16
IKK
NFKB
7490.093
uM
3.43830
4.18620
-0.7142 -0.7151 4.5114 0.3647
0.9985
2.3707
MCF12A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7490.091
uM
53.81120
77.89240
-0.6995 -0.7142 2.3989 0.2886
0.9978
2.5547
MCF12A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7489.09
uM
31.0410
41.980
-0.8584 -0.8585 3.3109 0.3463
0.9985
1.9790
MCF12A
NM
Basal B
Ispinesib
KSP
Kinesin
7490.067
uM
0.14468
2.57510
-0.6794 -1.0000 0.3816 0.4977
0.8901
2.6472
MCF12A
NM
Basal B
Ispinesib
KSP
Kinesin
7489.067
uM
0.10172
0.70953
-0.9138 -1.0000 0.5656 0.6199
0.9358
1.7603
MCF12A
NM
Basal B
Ixabepilone
TUBB
TUBB
7490.095
uM
0.01583
0.20763
-0.7211 -0.9087 0.4024 0.7905
0.9567
2.7242
MCF12A
NM
Basal B
JNK-IN-5A
JNK
JNK
12365.168
uM
87.14890
200.63390
-0.0145 -1.0000 1.3175 0.1430
0.8820
2.1914
MCF12A
NM
Basal B
JNK-IN-5A
JNK
JNK
10817.144
uM
1.52950
1.63410
-0.2935 -0.1960 5.0000 0.3934
0.9887
1.4640
MCF12A
NM
Basal B
L-779450
BRAF
MAPK
12365.166
uM
19.65440
49.33380
0.2431 -0.9485 1.1557 0.0557
0.9856
1.8961
MCF12A
NM
Basal B
L-779450
BRAF
MAPK
10817.149
uM
7.84630
9.93210
0.0505 -0.1663 1.2177 0.1275
0.9882
1.4656
MCF12A
NM
Basal B
LBH589
HDAC
HDAC
12365.167
uM
0.22436
0.57019
-0.6338 -0.6704 0.9118 0.5236
0.9989
2.0273
MCF12A
NM
Basal B
LBH589
HDAC
HDAC
10817.154
uM
0.96290
1.2080
-0.8736 -0.8706 4.4460 0.4940
0.9989
1.4551
MCF12A
NM
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10817.154
uM
0.57634
1.04690
-0.6076 -0.5571 1.2543 0.3966
0.9910
1.4551
MCF12A
NM
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12365.167
uM
0.49777
2.23750
-0.7263 -0.9507 0.7087 0.4221
0.9949
2.0273
MCF12A
NM
Basal B
Mebendazole
12949.174
uM
2.69550
4.30780
0.0553 -0.1473 0.5507 0.2817
0.9795
1.9016
MCF12A
NM
Basal B
Methotrexate
DHFR
Metabolism
7489.084
uM
inf
0.05529
0.6914 0.7635 4.9999 0.1630
0.8755
2.0279
MCF12A
NM
Basal B
Methotrexate
DHFR
Metabolism
7490.085
uM
0.28874
0.09371
0.3581 0.3802 1.2695 0.3975
0.9816
2.5778
MCF12A
NM
Basal B
Methylglyoxal
13508.184
uM
576.52490
995.81850
-0.8032 -0.7829 1.7240 0.5701
0.9916
2.2235
MCF12A
NM
Basal B
MG-132
Proteasome
Proteasome
14164.189
uM
0.02152
0.03005
-0.9933 -0.5632 2.2599 1.0599
0.6767
0.7884
MCF12A
NM
Basal B
MG-132
Proteasome
Proteasome
14164.189
uM
0.02152
0.03005
-0.9933 -0.5632 2.2599 1.0599
0.6767
0.7884
MCF12A
NM
Basal B
MG-132
Proteasome
Proteasome
12365.17
uM
0.03571
0.07223
-0.7143 -0.6743 1.2123 0.8940
0.9883
2.2930
MCF12A
NM
Basal B
MG-132
Proteasome
Proteasome
12365.17
uM
0.03571
0.07223
-0.7143 -0.6743 1.2123 0.8940
0.9883
2.2930
MCF12A
NM
Basal B
MG-132
Proteasome
Proteasome
10817.145
uM
0.05007
0.07304
-0.8603 -0.7796 2.4893 0.9493
0.9893
1.5564
MCF12A
NM
Basal B
MG-132
Proteasome
Proteasome
10817.145
uM
0.05007
0.07304
-0.8603 -0.7796 2.4893 0.9493
0.9893
1.5564